Interestingly, the damage associated with colitis resulted in a significant elevation of serum levels of CRP and MPO activity in the colon, while these elevated levels were notably reduced in those rats that received MSPNP treatment, which exerted their protective role against colon damage. The gene discussed is CRP; the disease is colitis.